ADVFN Logo ADVFN
Donnée du Marché
Actualité
Outils
Donnée du Marché
Discover

Hot Features

Follow Feed

Rester connecter avec les traders et investisseurs dans notre communauté Follow Feed.

Flux des Options

Explorez des données complètes sur les options et utilisez les filtres avancés avec Options Flow.

Moniteur

Organisez et surveillez vos d'actions et actifs avec le Moniteur.
Se connecter Premium IconPremium Help Menu
CAC 40
7 274,48
-0,27%
Dow Jones
42 840,26
1,18%
DAX
19 884,75
-0,57%
Brent Oil
72,72
0,00%
Bitcoin
95 973,52
-1,27%
Registration Strip Icon for monitor Surveillez plusieurs cotations en temps réel des principales bourses, telles que Euronext Paris, NASDAQ, NYSE, AMEX, Bovespa et plus encore.
S'inscrire
  1. Accueil
  2. Investir
  3. Actions
  4. Canadá
  5. CSE

  6. MindBio Therapeutics Corp (MBIO) Cours

MindBio Therapeutics Corp

MindBio Therapeutics Corp (MBIO)

Mustang Bio Inc
0,02
0,00
(0,00%)
Fermé 22 Décembre 10:00PM
Retardé de 15 minutes

Votre Hub pour des idées et discussions en direct en temps réel

Premium

Statistiques et détails clés

Dernier
0,02
Prix Achat
0,02
Prix Vente
0,025
Volume échangé
69 000
0,02 Fourchette du Jour 0,02
0,015 Plage de 52 semaines 0,085
Clôture Veille
0,02
Ouverture
0,02
Dernière Transaction
42000
@
0.02
Dernière heure de transaction
Volume moyen (3 m)
87 301
Volume financier
-
VWAP
-

MBIO Dernières nouvelles

Plus de nouvelles

Mindbio Therapeutics Begins Dosing MB22001 In Phase 2 Clinical Trial In World First Take-home Microdosing Study In Patients With Depression

  MINDBIO THERAPEUTICS BEGINS DOSING MB22001 IN PHASE 2 CLINICAL TRIAL IN WORLD FIRST TAKE-HOME MICRODOSING STUDY IN PATIENTS WITH DEPRESSION World-first take-home approvals...

24 Août 2023
InvestorsHub NewsWire

MindBio Therapeutics Breakthrough Discovery in Microdosing Clinical Trial Reveals Significant Positive Effects on Quality Of Sleep

MINDBIO THERAPEUTICS BREAKTHROUGH DISCOVERY IN MICRODOSING CLINICAL TRIAL REVEALS SIGNIFICANT POSITIVE EFFECTS ON QUALITY OF SLEEPNew Discovery:  MindBio's LSD-Microdosing Treatment Improves...

14 Juin 2023
InvestorsHub NewsWire

MindBio Therapeutics CEO Demonstrates how 1 Million Microdoses of LSD can Potentially be Used to Treat Depression at Scale

MINDBIO THERAPEUTICS CEO DEMONSTRATES HOW 1 MILLION MICRODOSES OF LSD CAN POTENTIALLY BE USED TO TREAT DEPRESSION 1 Million Microdoses used to create proprietary microdosing...

30 Mai 2023
InvestorsHub NewsWire

MindBio Therapeutics Ethics Approval for Landmark World First Phase 2 Clinical Trial of Take-Home LSD-Microdosing for Major Depressive Disorder

 ETHICS APPROVAL FOR LANDMARK WORLD FIRST PHASE 2 CLINICAL TRIAL OF TAKE-HOME LSD-MICRODOSING FOR MAJOR DEPRESSIVE DISORDEREthics approval received for take-home LSD-Microdosing clinical...

23 Mai 2023
InvestorsHub NewsWire

MindBio Therapeutics Phase 2 Clinical Trial Has Received Ethics Approval for World First Take-Home LSD-Microdosing Trials in Cancer Patients Experiencing Emotional Distress

PHASE 2 CLINICAL TRIAL HAS RECEIVED ETHICS APPROVAL FOR WORLD FIRST TAKE-HOME LSD-MICRODOSING TRIALS IN CANCER PATIENTS EXPERIENCING EMOTIONAL DISTRESSEthics approval granted The clinical trial...

11 Mai 2023
InvestorsHub NewsWire

MindBio Therapeutics Corp (CSE: MBIO) Reveals Scientific Paper in World-First Take-Home, LSD-Microdosing Clinical Trial in 80 Healthy Participants

MindBio Therapeutics Corp (CSE: MBIO) Reveals Scientific Paper in World-First Take-Home, LSD-Microdosing Clinical Trial in 80 Healthy Participants   MindBio clinical trial...

09 Mai 2023
InvestorsHub NewsWire
PériodeVariationVariation %Ouver.HautBasMoyenne Vol. Quot.VWAP
1000.020.0250.015554880.02CS
4-0.005-200.0250.0250.015407320.02131584CS
12-0.01-33.33333333330.030.0350.015873010.02459854CS
26-0.025-55.55555555560.0450.050.015600370.02763638CS
52-0.005-200.0250.0850.015582410.03820424CS
156-0.54-96.42857142860.560.560.015657410.05729122CS
260-0.54-96.42857142860.560.560.015657410.05729122CS

MBIO - Frequently Asked Questions (FAQ)

What is the current MindBio Therapeutics share price?
The current share price of MindBio Therapeutics is $ 0,02
What is the 1 year trading range for MindBio Therapeutics share price?
MindBio Therapeutics has traded in the range of $ 0,015 to $ 0,085 during the past year

Moteurs

Voir tout
  • Volume
  • % Gagnants
  • % Perdants
SymbolePrixVol.
XBLK.XeXeBlock Technology Corporation
$ 0,05
(150,00%)
312,24k
CCRGreen River Gold Corp
$ 0,01
(100,00%)
2,1k
KVMKingsview Minerals Ltd
$ 0,01
(100,00%)
1 000
MYTCMyndTec Inc
$ 0,20
(100,00%)
1 000
AJNAJN Resources Inc
$ 0,10
(81,82%)
12k
XCXAMP Alternative Medical Products Inc
$ 0,01
(-89,47%)
2k
MJRXGlobal Health Clinics Ltd
$ 0,01
(-75,00%)
7,5k
NIRVNirvana Life Sciences Inc
$ 0,025
(-66,67%)
3k
CLSHCLS Holdings USA Inc
$ 0,02
(-60,00%)
60,26k
PMAXPowermax Minerals Inc
$ 0,70
(-51,72%)
5,5k
TRIPRed Light Holland Corp
$ 0,04
(0,00%)
3,53M
QIMCQuebec Innovative Materials Corp
$ 0,09
(5,88%)
2,17M
SOLSOL Global Investments Corp
$ 0,36
(0,00%)
2,05M
HODLSol Strategies Inc
$ 2,64
(23,36%)
1,73M
AFXArctic Fox Lithium Corp
$ 0,005
(-50,00%)
1,45M

Forums

Afficher les forums
Aucune Discussion Trouvée
Ajouter une Discussion

Dernières Valeurs Consultées

CSE
MBIO
MindBio Therapeutics
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

France
Société
Entreprise
Popular
Obtenir l'application
App Store
Google Play

Assistance: support@advfn.fr

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales

© 2024 ADVFN PLC - Tous droits réservés